Golden has been acquired by ComplyAdvantage.Read about it here ⟶

Annexon

Annexon is an innovative neurodegeneration therapeutics by targeting complement company founded in 2011 by Ben Barres.

Overview Structured Data Issues Contributors Activity

gust.com/c/annexon

Is a

Company attributes

Industry

Location

Palo Alto, California

Brisbane, California

0

B2X

0

CEO

0

Founder

Arnon Rosenthal

AngelList URL

angel.co/annexon-1

Pitchbook URL

pitchbook.com/profiles...100468-45

Legal Name

Annexon, Inc.

Number of Employees (Ranges)

51 – 200

Email Address

info@annexonbio.com0

Phone Number

+165082255000

Full Address

1400 Sierra Point Parkway, Building C, 2nd Floor Brisbane, CA 94005, USA0

CIK Number

Place of Incorporation

0

DUNS Number

9697877410

IRS Number

275,414,4230

Founded Date

2011

0

Fax Number

650.636.97730

Total Funding Amount (USD)

101,999,983

Latest Funding Round Date

July 2020

Stock Symbol

ANNX0

Exchange

0

Board of Directors

Thomas G. Wiggans

0

William H. Carson

0

0

0

CAGE Code

6K3S30

Wellfound ID

Country

Other attributes

Company Operating Status

Active

SIC Code

2,8340

Ticker Symbol

ANNX

No article content yet.

Timeline

No Timeline data yet.

Funding Rounds

Products

Acquisitions

SBIR/STTR Awards

Patents

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more companies like Annexon

Use the Golden Query Tool to find similar companies in the same industry, location, or by any other field in the Knowledge Graph.

Open Query Tool

Golden Query Tool